Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation NY Valves 2024

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

Presenter: Martin Maron

June 07, 2024

Presentation NY Valves 2024

Understanding the Genetics and Classification of Connective Tissue Syndromes

Presenter: Amy Kontorovich

June 07, 2024

Presentation THT 2024

HCM Genetics- Prognostic/Therapeutic Implications and Counseling

Presenter: Carolyn Ho

March 04, 2024

Presentation TCT 2022

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

Presenter: Seung Hun Lee

September 19, 2022

Presentation SCAD 2022

Genetics of SCAD, and When & What to Investigate?

Presenter: Santhi K. Ganesh

February 19, 2022

Presentation SCAD 2021

New genetic discoveries for SCAD, and when should genetic studies be done?

Presenter: Santhi K. Ganesh

January 30, 2021

Presentation TCT 2014

Epidemiology and Genetics

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, Carolyn Ho

September 16, 2014

Presentation TCT 2013

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

Presenter: H. Robert Superko

October 31, 2013

Presentation TCT 2012

Platelet Reactivity, Genetics, and Thienopyridine Responsiveness: Theoretical and Real-world Implications

Presenter: Matthew Price

October 22, 2012

Advertisement

A Clinical Approach to Genetics in Hypertrophic Cardiomyopathy

Understanding the Genetics and Classification of Connective Tissue Syndromes

HCM Genetics- Prognostic/Therapeutic Implications and Counseling

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

Genetics of SCAD, and When & What to Investigate?

New genetic discoveries for SCAD, and when should genetic studies be done?

Epidemiology and Genetics

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

Platelet Reactivity, Genetics, and Thienopyridine Responsiveness: Theoretical and Real-world Implications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content